Drugs / SIIV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05981846 | Sep → Oct 2023 | COVID-19, influenza | Hipra Scientific, S.L.U | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SIIV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05981846 ↗ |
| Modality | Vaccine | “seasonal surface antigen inactivated adjuvanted influenza vaccine (SIIV)” NCT05981846 ↗ |